← Back to Search

Diaphragmatic Breathing for Esophageal Disorders

N/A
Recruiting
Led By Andree Koop, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* patients undergoing high-resolution esophageal manometry
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year.
Awards & highlights

Summary

"This trial aims to find out which body position or movements create the most pressure in a specific part of the esophagus, which can help strengthen the diaphragm."

Who is the study for?
This trial is for patients who are already scheduled to undergo high-resolution esophageal manometry, a test that measures muscle contractions in the esophagus. It's aimed at those with conditions like acid reflux or difficulty swallowing.
What is being tested?
The study is testing how diaphragmatic breathing affects pressure at the EGJ (the valve between the esophagus and stomach). Researchers want to find out which positions or maneuvers increase this pressure most effectively.
What are the potential side effects?
Since the intervention involves only diaphragmatic breathing exercises, no significant side effects are expected. However, discomfort from the manometry procedure itself may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pressure at the esophagogastric junction

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diaphragmatic breathing protocolExperimental Treatment1 Intervention
All patients will undergo the diaphragmatic breathing protocol with high-resolution esophageal manometry.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
diaphragmatic breathing
2023
N/A
~100

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,958,415 Total Patients Enrolled
Andree Koop, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
60 Total Patients Enrolled
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top